Moderate To Severe Submental Fat Therapeutics
1. Kybella patent expiration
Treatment: Method for reduction of submental fat; Improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults by means of reducing submental fat volume as de...
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US8242294 | ABBVIE | Synthetic bile acid compositions and methods |
May, 2028
(2 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7622130 | ABBVIE | Methods and compositions for the non-surgical removal of fat |
Dec, 2027
(1 year, 10 months from now) | |
| US7754230 | ABBVIE | Methods and related compositions for reduction of fat |
Dec, 2027
(1 year, 10 months from now) | |
| US8846066 | ABBVIE | Methods and related compositions for reduction of fat and skin tightening |
Feb, 2025
(10 months ago) | |
| US12161653 | ABBVIE | Treatment of submental fat |
Feb, 2032
(6 years from now) | |
| US8298556 | ABBVIE | Methods and related compositions for the non-surgical removal of fat |
Aug, 2025
(5 months ago) | |
| US9949986 | ABBVIE | Synthetic bile acid compositions and methods |
Feb, 2028
(2 years from now) | |
| US9636349 | ABBVIE | Synthetic bile acid compositions and methods |
Feb, 2028
(2 years from now) | |
| US9522155 | ABBVIE | Synthetic bile acid compositions and methods |
Feb, 2028
(2 years from now) | |
| US8546367 | ABBVIE | Synthetic bile acid compositions and methods |
Feb, 2028
(2 years from now) | |
| US8461140 | ABBVIE | Synthetic bile acid compositions and methods |
Feb, 2028
(2 years from now) | |
| US8653058 | ABBVIE | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
Mar, 2030
(4 years from now) | |
| US8367649 | ABBVIE | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(4 years from now) | |
| US8101593 | ABBVIE | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(4 years from now) | |
| US10500214 | ABBVIE | Formulations of deoxycholic acid and salts thereof |
Mar, 2030
(4 years from now) | |
| US8883770 | ABBVIE | Synthetic bile acid compositions and methods |
Feb, 2028
(2 years from now) | |
Drugs and Companies using DEOXYCHOLIC ACID ingredient
Market Authorisation Date: 29 April, 2015
Dosage: SOLUTION
How can I launch a generic of KYBELLA before it's drug patent expiration?
More Information on Dosage
KYBELLA family patents
